Argyria attributed to silvadene application in a patient with dystrophic epidermolysis bullosa

John C. Browning, Moise L. Levy

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Abstract

Argyria is most commonly reported in association with prolonged ingestion of silver-containing medicaments. This case illustrates the rather unique case of development of argyria following application of silver sulfadiazine in a patient with epidermolysis bullosa.

Original languageEnglish (US)
Article number9
JournalDermatology online journal
Volume14
Issue number4
StatePublished - Apr 1 2008
Externally publishedYes

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Argyria attributed to silvadene application in a patient with dystrophic epidermolysis bullosa'. Together they form a unique fingerprint.

Cite this